Cargando…
CRISPR/Cas Derivatives as Novel Gene Modulating Tools: Possibilities and In Vivo Applications
The field of genome editing started with the discovery of meganucleases (e.g., the LAGLIDADG family of homing endonucleases) in yeast. After the discovery of transcription activator-like effector nucleases and zinc finger nucleases, the recently discovered clustered regularly interspaced short palin...
Autores principales: | Xu, Xingbo, Hulshoff, Melanie S., Tan, Xiaoying, Zeisberg, Michael, Zeisberg, Elisabeth M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246536/ https://www.ncbi.nlm.nih.gov/pubmed/32344896 http://dx.doi.org/10.3390/ijms21093038 |
Ejemplares similares
-
High-fidelity CRISPR/Cas9- based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosis
por: Xu, Xingbo, et al.
Publicado: (2018) -
Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1
por: Wilhelmi, Tim, et al.
Publicado: (2020) -
DNMT1 and HDAC2 Cooperate to Facilitate Aberrant Promoter Methylation in Inorganic Phosphate-Induced Endothelial-Mesenchymal Transition
por: Tan, Xiaoying, et al.
Publicado: (2016) -
Precision renal medicine: a roadmap towards targeted kidney fibrosis therapies
por: Zeisberg, Michael, et al.
Publicado: (2015) -
miR-132-3p and KLF7 as novel regulators of aortic stiffening-associated EndMT in type 2 diabetes mellitus
por: Hulshoff, Melanie S., et al.
Publicado: (2023)